INDEGENE
Back to Cashflow Statement
|
INDEGENE Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹288 Cr | ₹-66 Cr | ₹333 Cr | ₹233 Cr | ₹-132 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDEGENE ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹288 Cr |
| Mar2024 | ₹-66 Cr |
| Mar2023 | ₹333 Cr |
| Mar2022 | ₹233 Cr |
| Mar2021 | ₹-132 Cr |
How is Cash Flow from Financing Activities of INDEGENE Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹288 Cr | Positive | |
| Mar2024 | ₹-66 Cr | Negative | |
| Mar2023 | ₹333 Cr | 42.67 | |
| Mar2022 | ₹233 Cr | Positive | |
| Mar2021 | ₹-132 Cr | - | |
Compare Cash Flow from Financing Activities of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹11,940.8 Cr | -2.4% | -5.4% | -16.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -6.4% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -5.8% | -1.6% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | 1.4% | 7% | 23.7% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -4.7% | -6.8% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -2.8% | -8.1% | -11.1% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | -2.4% |
-5.4% |
-16.1% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses